---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-010378"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2023-03-31T23:59:59+00:00"
generated_at: "2026-06-17T07:55:50.013259+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# PAVmed stockholders approve reverse stock split and authorized share reduction

## Summary
- Approximately 70.8% of shares present or represented at March 31 special meeting.
- Reverse split ratio range 1:5 to 1:15, board to decide timing and exact ratio by March 31, 2024.
- Authorized shares reduced from 250M to 50M upon effectuation of reverse split.
- Votes: 53,080,020 for, 15,037,559 against, 1,009,870 abstain, no broker non-votes.
- Company reserved right to abandon the reverse split and authorized capital reduction.

## SEC filing metadata
- accession: 0001493152-23-010378
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2023-03-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000149315223010378/0001493152-23-010378-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000149315223010378/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-010378
- JSON: https://secwatch.observer/filing/0001493152-23-010378.json
- Plain text: https://secwatch.observer/filing/0001493152-23-010378.txt

## Key facts
- Shareholder Votes
  PAVmed Inc. shareholders approved A proposal to approve an amendment to the certificate of incorporation to effect a reverse stock split and an associated reduction in authorized shares at the 2023-03-31 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-03-31
  source text: Stockholders representing approximately 70.8% of the shares outstanding and entitled to vote were present in person or by proxy. At the Special Meeting, the stockholders approved the sole proposal presented.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1624326/000149315223010378/0001493152-23-010378-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.